Navigation Links
DePuy & Transvaginal Mesh Lawsuit Settlement Funding Leads Legal-Bay to Banner 2nd Quarter
Date:7/10/2012

NEW YORK, July 10, 2012 /PRNewswire/ -- Legal-Bay LLC, the lawsuit settlement funding company, announced today that the company had a robust 2nd quarter mostly due to high volume in assisting victims with pre-settlement funding of the DePuy and Johnson & Johnson Hip Implant Recall, as well as Transvaginal Mesh products.  Additionally, the company expanded its operations to a new "state of the art" facility with increased staff, additional funding capital, and newly aligned marketing partners. 

The sales of both DePuy and the various mesh cases (vaginal, pelvic, bladder slings, and hernia Kugel mesh) were due to both of the litigations slowing down without any settlement news.  However, Legal-Bay believes that the average settlement value for both DePuy and transvaginal mesh cases could be from $500K to $1mm depending on damages and other factors.  Legal-Bay provides individuals with what plaintiff's refer to as "lawsuit loans" with up to $50K on each of these cases.  However, the lawsuit cash advance is not a lawsuit loan and only needs to be paid back if the case is actually won. 

Patty Kirby, Head of Client Relations, commented about the company's success, "Most of our DePuy lawsuit funding and Mesh clients cannot wait and need money today, so our program enables them to access $50K immediately off their case and still be left with approximately $450K at settlement on a case valued at $500K. The 2nd quarter our applications were up across the board, as we have recently launched a separate division for accident lawsuit funding cases.  We added staff to handle this influx of business.  We are now equipped to handle the largest funding cases with extremely low rates and the absolute fastest turnaround time's industry wide."

Legal-Bay says that they have also seen substantial growth in Commercial Litigation, Quit Tam or Whistleblower, Wrongful Imprisonment, FELA, Jones Act, Mesothelioma, and Actos Pharmaceutical case funding in 2012. 

Plaintiffs in need of a DePuy, Transvaginal Mesh lawsuit funding, car or commercial truck accident funding or any other lawsuit settlement funding can apply directly to lawsuitssettlementfunding.com or call toll free at 877.571.0405 where agents are standing by 24 hours a day to assist you. 

Contact:  Patty Kirby, Head of Client Relations info@legal-bay.com, ph. 877.571.0405


'/>"/>
SOURCE Legal-Bay LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
2. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
3. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
4. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
5. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
8. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
9. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
10. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
11. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 26, 2016 A key trend ... the emergence of new treatments. Cardax, a development stage ... treatment. The therapy is expected to fulfil large unmet ... is conducting studies to develop new treatments for osteoarthritis. ... genes involved in osteoarthritis are being investigated, and early ...
(Date:5/26/2016)... , May 26, 2016   Change ... and analytics, network solutions and technology-enabled services ... it entered into a strategic channel partnership ... outpatient software solutions and revenue cycle management ... hospitals and rehabilitation clinics to optimize revenue, ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
Breaking Medicine Technology:
(Date:5/26/2016)... , ... May 26, 2016 , ... ... to oncology professionals, has added National Cancer Institute-designated University of Virginia (UVA) ... In this new partnership, OncLive’s editorial and marketing teams will publicize and promote ...
(Date:5/26/2016)... ... May 26, 2016 , ... A health conscious snack that ... Dough Bar, has ignited an undeniable buzz in the protein product community by ... just any doughnut.  These doughnuts are packed with 11 grams of protein and made ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... provide strategic sales leadership and to further develop their rapidly expanding portfolio of ... Business Administration with a concentration in Marketing and an M.B.A. with concentration in ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... efforts for several years, and the efforts have paid off. Since implementation ... new standards of care to enhance perioperative patient experiences and reduce costly complications. ...
(Date:5/26/2016)... ... , ... Dr. LeRoy Perry’s recently authored whitepaper, “Tech Neck and ROI (return ... of users, hundreds of millions of whom are coming into the workplace with pain ... common action of looking down at hand-held technology devices (tablets, smartphones) for extended periods ...
Breaking Medicine News(10 mins):